David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CALL
Matador Resources
MTDR
$6.84B
| $3.36M | ﹤0.01% |
70,500
+17,900
| +34% | +$790K |
|
2227
Rambus
RMBS
$9.76B
| $3.36M | ﹤0.01% |
52,532
-4,226
| -7% | -$226K |
|
2228
Aaon
AAON
$6.58B
| $3.36M | ﹤0.01% |
45,550
-49,405
| -52% | -$4.33M |
|
2229
Merchants Bancorp
MBIN
$2.46B
| $3.36M | ﹤0.01% |
101,535
+196
| +0.2% | +$6.34K |
|
2230
Helios Technologies
HLIO
$2.47B
| $3.36M | ﹤0.01% |
100,616
+54,334
| +117% | +$1.64M |
|
2231
SLB Ltd
SLB
$79.5B
| $3.36M | ﹤0.01% |
99,274
+76,045
| +327% | +$2.64M |
|
2232
CALL
Transmedics
TMDX
$3.2B
| $3.35M | ﹤0.01% |
25,000
-5,000
| -17% | -$549K |
|
2233
CALL
Northrop Grumman
NOC
$78.1B
| $3.35M | ﹤0.01% |
6,700
-1,600
| -19% | -$787K |
|
2234
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
| $3.35M | ﹤0.01% |
114,668
+66,471
| +138% | +$1.76M |
|
|
SVCC
2235
Stellar V Capital Corp
SVCC
$230M
| $3.35M | ﹤0.01% |
+327,290
| New | +$3.3M |
|
|
BBT
2236
Beacon Financial Corp
BBT
$2.66B
| $3.34M | ﹤0.01% |
133,418
+24,658
| +23% | +$613K |
|
2237
nCino
NCNO
$2.36B
| $3.33M | ﹤0.01% |
118,985
+97,022
| +442% | +$2.42M |
|
2238
CALL
Rio Tinto
RIO
$170B
| $3.32M | ﹤0.01% |
+57,000
| New | +$3.37M |
|
2239
Cleveland-Cliffs
CLF
$6.58B
| $3.32M | ﹤0.01% |
437,471
-268,393
| -38% | -$1.99M |
|
2240
Citi Trends
CTRN
$576M
| $3.32M | ﹤0.01% |
99,571
+24,332
| +32% | +$620K |
|
|
PGAC
2241
Pantages Capital Acquisition Corp
PGAC
| $3.31M | ﹤0.01% |
325,000
| – | – |
|
|
2242
CALL
Intuit
INTU
$94.6B
| $3.31M | ﹤0.01% |
4,200
-15,900
| -79% | -$10.8M |
|
|
DQ
2243
CALL
Daqo New Energy
DQ
$915M
| $3.3M | ﹤0.01% |
217,700
-25,400
| -10% | -$361K |
|
2244
PUT
BioMarin Pharmaceuticals
BMRN
$12.7B
| $3.3M | ﹤0.01% |
60,000
| – | – |
|
2245
State Street SPDR S&P Insurance ETF
KIE
$712M
| $3.28M | ﹤0.01% |
+54,941
| New | +$3.19M |
|
2246
Park National Corp
PRK
$3.6B
| $3.28M | ﹤0.01% |
19,609
+6,523
| +50% | +$1.03M |
|
2247
Agilon Health
AGL
$1.61B
| $3.28M | ﹤0.01% |
57,038
+17,494
| +44% | +$1.4M |
|
2248
Broadridge
BR
$20.7B
| $3.28M | ﹤0.01% |
13,487
-7,671
| -36% | -$1.82M |
|
2249
PUT
Polaris
PII
$3.63B
| $3.28M | ﹤0.01% |
80,600
-26,900
| -25% | -$1.01M |
|
2250
Vericel Corp
VCEL
$2.17B
| $3.28M | ﹤0.01% |
76,995
-20,617
| -21% | -$858K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.